May 13, 2024
Home AstraZeneca
Finance

AstraZeneca acquires Fusion Pharmaceuticals in $2B deal

  • March 19, 2024

AstraZeneca (AZN) has announced its acquisition of Fusion Pharmaceuticals (FUSN), a Canadian drug developer, in an all-cash deal valued at $2 billion. This strategic move aims to bolster AstraZeneca’s presence in the oncology space. Yahoo Finance’s Anjalee Khemlani breaks down the details. For more expert insight and the latest market action, click here to watch

Read More
Investment

Opinion | Why stock market stars are at odds with real world’s investment needs

  • March 2, 2024

We should be asking much deeper questions now than simply about whether and when another stock market bubble burst might come. We should be re-examining the role of private and public sectors in allocating financial resources to the global economy. Failure to do this could result in a dramatic rise in tax rates around the

Read More